Georgieva ZG, Dffinger R, Kumararatne D, Coles AJ, et al. Diminished seroconversion following a single SARS-COV-2 vaccine in
ocrelizumab-treated relapsing-remitting multiple sclerosis patients. Mult Scler 2021 Oct 1:13524585211046786. doi: 10.1177/13524585211046786.
PMID: 34595965